Claim Check: "Clinically Proven" Based on One Small Study
What "clinically proven" can and cannot mean when it rests on a single small study, why small trials overstate effects, and what better evidence looks like.
Content last updated . This page has not been medically reviewed.
The claim
"Clinically proven" appears on supplements, devices, apps and clinic menus. The phrase sounds final, but one small study cannot make a product proven. This page checks the claim as information only. Evidence labels: promising but limited, insufficient evidence, marketing claim, explained in how we label evidence.Short verdict
Marketing claim when it rests on one small study. A single small trial can be an early signal worth testing again. It is not proof that a product works, for whom, or at what cost in side effects.Why one small study is weak evidence
- Small trials tend to show bigger effects. A study of 93 meta-analyses (735 trials) found treatment effects averaged 48% larger in trials with fewer than 50 patients than in trials with 1,000 or more (ratio of odds ratios 0.52, 95% confidence interval 0.41 to 0.66). [1]
- Chance and bias matter more. An influential analysis argues a research finding is less likely to be true when studies in a field are smaller, effect sizes are smaller, or there is greater financial interest and flexibility in designs and outcomes. [2]
- Replication matters. The US Federal Trade Commission (FTC) guidance for health advertisers says replication in a second, independent study reduces the chance that one trial's results reflect bias. [3]
- Studies must fit the claim. The FTC says advertisers should not rely on research on a specific test population for claims aimed at the general population. [3] It also asks how the advertised product's dose and formulation compare with the product studied. [3]
Questions to ask
| Question | Why |
|---|---|
| Was it done in people, not cells or animals? | See cell studies vs animal studies vs human trials |
| How many people, and was there a comparison group? | Small, uncontrolled studies mislead |
| Was the measured result a lab number or how people feel? | See biomarkers vs clinical outcomes |
| Was it repeated by independent researchers? | See replication and reproducibility |
| Is it the same product, dose and population? | The study must match the claim |
| Who paid for it? | Funding can shape design and reporting |
Related claim checks
For the version aimed at peptides, see claim check: clinically proven without a matching human trial. To judge study size and certainty, see reading early-stage research.Frequently asked questions
Is one randomized trial enough to prove something?
Usually not on its own. The FTC guidance says independent replication reduces the chance a single trial reflects bias. [3]
Why do small studies show bigger effects?
Across 93 meta-analyses, smaller trials had larger average effects than the largest trials, which suggests small trials can overstate benefit. [1]
Does a published study mean the result is true?
Not always. One analysis argues findings are less likely to be true when studies are small and the field has strong interests or flexible designs. [2]
Is the claim always wrong?
No. A product could be backed by several good trials. The point is to check what the claim rests on.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
What the regulator says about substantiation
Safety note
References
- Influence of trial sample size on treatment effect estimates: meta-epidemiological study, BMJ 2013 (PubMed 23616031). Read 2026-10-22.
- Why most published research findings are false, PLoS Med 2005 (PubMed 16060722). Read 2026-10-22.
- US Federal Trade Commission, Health Products Compliance Guidance. Read 2026-10-22.